Innovations in thoracic imaging: CT, radiomics, AI and x-ray velocimetry
- PMID: 35965430
- PMCID: PMC9546393
- DOI: 10.1111/resp.14344
Innovations in thoracic imaging: CT, radiomics, AI and x-ray velocimetry
Abstract
In recent years, pulmonary imaging has seen enormous progress, with the introduction, validation and implementation of new hardware and software. There is a general trend from mere visual evaluation of radiological images to quantification of abnormalities and biomarkers, and assessment of 'non visual' markers that contribute to establishing diagnosis or prognosis. Important catalysts to these developments in thoracic imaging include new indications (like computed tomography [CT] lung cancer screening) and the COVID-19 pandemic. This review focuses on developments in CT, radiomics, artificial intelligence (AI) and x-ray velocimetry for imaging of the lungs. Recent developments in CT include the potential for ultra-low-dose CT imaging for lung nodules, and the advent of a new generation of CT systems based on photon-counting detector technology. Radiomics has demonstrated potential towards predictive and prognostic tasks particularly in lung cancer, previously not achievable by visual inspection by radiologists, exploiting high dimensional patterns (mostly texture related) on medical imaging data. Deep learning technology has revolutionized the field of AI and as a result, performance of AI algorithms is approaching human performance for an increasing number of specific tasks. X-ray velocimetry integrates x-ray (fluoroscopic) imaging with unique image processing to produce quantitative four dimensional measurement of lung tissue motion, and accurate calculations of lung ventilation.
Keywords: computed tomography; deep learning; lung cancer; lung nodules; machine learning; radiomics; x-ray velocimetry.
© 2022 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.
Conflict of interest statement
Rozemarijn Vliegenthart is supported by an institutional research grant from Siemens Healthineers. Colin Jacobs is supported by an institutional research grant from MeVis Medical Solutions and his institution receives royalties from MeVis Medical Solutions for the development of Veolity, a reading platform for lung cancer screening. Nikolaos Papanikolaou is the owner of MRIcons LTD. Andreas Fouras is a founder and CEO of 4DMedical, a global medical technology company.
Figures





Similar articles
-
Artificial intelligence-driven assessment of radiological images for COVID-19.Comput Biol Med. 2021 Sep;136:104665. doi: 10.1016/j.compbiomed.2021.104665. Epub 2021 Jul 21. Comput Biol Med. 2021. PMID: 34343890 Free PMC article. Review.
-
Localized thin-section CT with radiomics feature extraction and machine learning to classify early-detected pulmonary nodules from lung cancer screening.Phys Med Biol. 2018 Mar 14;63(6):065005. doi: 10.1088/1361-6560/aaafab. Phys Med Biol. 2018. PMID: 29446758
-
Artificial intelligence: A critical review of applications for lung nodule and lung cancer.Diagn Interv Imaging. 2023 Jan;104(1):11-17. doi: 10.1016/j.diii.2022.11.007. Epub 2022 Dec 10. Diagn Interv Imaging. 2023. PMID: 36513593 Review.
-
A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence.Comput Biol Med. 2021 Mar;130:104210. doi: 10.1016/j.compbiomed.2021.104210. Epub 2021 Jan 18. Comput Biol Med. 2021. PMID: 33550068 Free PMC article. Review.
-
[Performance of Deep-learning-based Artificial Intelligence on Detection of Pulmonary Nodules in Chest CT].Zhongguo Fei Ai Za Zhi. 2019 Jun 20;22(6):336-340. doi: 10.3779/j.issn.1009-3419.2019.06.02. Zhongguo Fei Ai Za Zhi. 2019. PMID: 31196366 Free PMC article. Chinese.
Cited by
-
Chest computed tomography for patients with sepsis in the emergency intensive care unit.Sci Data. 2024 Nov 20;11(1):1261. doi: 10.1038/s41597-024-04132-z. Sci Data. 2024. PMID: 39567547 Free PMC article.
-
Artificial Intelligence-Empowered Radiology-Current Status and Critical Review.Diagnostics (Basel). 2025 Jan 24;15(3):282. doi: 10.3390/diagnostics15030282. Diagnostics (Basel). 2025. PMID: 39941212 Free PMC article. Review.
-
Environmental and occupational bronchiolitis obliterans: new reality.EBioMedicine. 2023 Sep;95:104760. doi: 10.1016/j.ebiom.2023.104760. Epub 2023 Aug 18. EBioMedicine. 2023. PMID: 37598462 Free PMC article. Review.
-
Radiomics analysis based on contrast-enhanced MRI for predicting short-term efficacy of drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma.Abdom Radiol (NY). 2024 Jul;49(7):2387-2400. doi: 10.1007/s00261-024-04319-3. Epub 2024 Jul 19. Abdom Radiol (NY). 2024. PMID: 39030402
-
Study rationale and design of the PEOPLHE trial.Radiol Med. 2024 Mar;129(3):411-419. doi: 10.1007/s11547-024-01764-4. Epub 2024 Feb 6. Radiol Med. 2024. PMID: 38319494 Free PMC article.
References
-
- Kauczor H‐U, Baird A‐M, Blum TG, Bonomo L, Bostantzoglou C, Burghuber O, et al. ESR/ERS statement paper on lung cancer screening. Eur Radiol. 2020;30:3277–94. - PubMed
-
- US Preventive Services Task Force , Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, et al. Screening for lung cancer: US preventive services task force recommendation statement. JAMA. 2021;325:962–70. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical